20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3S1149 | Ganoderic acid G | Others | |
Ganoderic acid G is isolated from the surface of Ganoderma lucidum tube layer. | |||
T5S1131 | Ganoderic acid C6 | Others | |
1. Ganoderic acid C6 has antinociceptive activity. | |||
T11363 | Ganoderic acid F | Others | |
Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium si... | |||
TN1661 | Ganoderic acid C2 | Reductase , Histamine Receptor , Immunology/Inflammation related | |
Ganoderic acid C2 has anti-inflammatory,and anti-tumor-promoting activities. Ganoderic acid C2 can inhibit histamine release, it also has inhibitory effects on the induction of Epstein-Barr Virus early antigen. | |||
TN1664 | Ganoderic acid H | NF-κB , DNA/RNA Synthesis , CDK | |
Ganoderic acid H is a potent antitumour agent, it mediates its biological effects through the inhibition of transcription factors AP-1 and NF-kappaB, resulting in the down-regulation of expression of Cdk4. | |||
TN1059 | Ganoderic acid B | IL Receptor , HIV Protease , JAK , STAT | |
Ganoderic acid B is a chemical marker in quality control of G. lucidum and related products. Ganoderic acid B-containing herbs has potential influence towards therapeutic window of trifluoperazine.Ganoderic acid B has an... | |||
TN1553 | Deacetyl ganoderic acid F | Others | |
Deacetyl ganoderic acid F (DeGA F), a triterpenoid extracted from Ganoderma lucidum, inhibits lipopolysaccharide (LPS)-induced inflammation in vitro and in vivo. | |||
T6S1141 | Ganoderic acid A | Apoptosis , NF-κB , Endogenous Metabolite , Autophagy | |
1. Ganoderic acid A exhibits antitumor activity, mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1. 2. Ganoderic acid A can induce proliferation inhibition, apoptosis a... | |||
T5S1133 | Ganoderic acid D | Apoptosis , Sirtuin | |
1. Ganoderic acid D is one of the major components in Ganoderma triterpenes. 2. Ganoderic acid D treatment for 48h inhibits the proliferation of HeLa human cervical carcinoma cells with an IC(5) value of 17.3 +/- .3 micr... | |||
TMA0993 | Ganoderic acid E | Ganoderic acid F | Antiviral |
Ganoderic acid F has anti-hepatitis B, anti-inflammatory, and anti-tumor-promoting activities. | |||
TN4106 | Ganoderic acid TN | Others | |
Ganoderic acid TN is a natural product. The catalog number is TN4106 and the CAS number is 112430-64-5. Ganoderic acid TN can be used as a reference standard. | |||
TN4104 | Ganoderic acid SZ | Others | |
Ganoderic acid SZ is a natural product. The catalog number is TN4104 and the CAS number is 865543-37-9. Ganoderic acid SZ can be used as a reference standard. | |||
T38396 | Ganoderic acid J | ||
Ganoderic acid J, a natural terpenoid extracted from Ganoderma lucidum fungus, exhibits anti-inflammatory properties. | |||
TN1665 | Ganoderic acid I | Others | |
Ganoderic acid I is a natural product from Ganoderma lucidum . | |||
TN4108 | Ganoderic acid Z | Antifection | |
The binding affinities of ganoderic acid DM and ganoderic acid Z (ÎGbind, -16.83 and-10.99 kcal mol-1) are comparable to that of current commercial drug oseltamivir (-23.62 kcal mol-1);Ganoderic acid DM is a potential s... | |||
TN4103 | Ganoderic acid K | ||
Ganoderic acid K is an angiotensin-converting enzyme inhibitor. It has anti-tumor, and anti-inflammatory activities. | |||
TMA1008 | Ganoderic acid S | Others | |
A novel combination of triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS), the composition is suitable for the t... | |||
T40373 | Ganoderic acid ε | ||
Ganoderic acid ε, a naturally occurring terpenoid, is extracted from the Fungus Ganoderma lucidum. This compound possesses an ED 50 value of 12.2 μg/mL, as demonstrated in its impact on Meth-A tumor cells. | |||
TN4107 | Ganoderic acid X | ERK , Mdm2 , MAPK , Caspase , Topoisomerase , JNK , p53 | |
Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells. | |||
TN1660 | Ganoderic acid C1 | IL Receptor , TNF , NF-κB , MAPK , COX , HIV Protease , DNA/RNA Synthesis | |
Ganoderic acid C1 has anti-inflammatory activity, has potential for treating TNF-α± mediated inflammation in asthma and other inflammatory diseases. Ganoderic acid C1 has anti-tumor-promoting activity. It is moderately a... |